SNX10 and neoplasm: In contrast to our findings, SNX10 was reported to have a tumor suppressive effect in mouse inflammation-driven colorectal cancer models, with knockout leading to increased chaperone-mediated autophagy and mTOR activation (37, 59) and reduced autophagic degradation of SRC (60).